This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Pediatrics  • Neonatology and Infant Care  • Pediatrics, Other  • Immunization  • World Health  • Malaria  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2009;301(3):263.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Findings from 2 double-blind, randomized trials in Africa demonstrate that a new malaria vaccine is effective at preventing both infection and the mosquito-borne disease itself in infants and children.

In one study, 894 children 5 to 17 months of age in Kenya and Tanzania were randomly assigned to receive 3 doses of the RTS, S/AS01E malaria vaccine or a control vaccine (for rabies), 809 of whom completed the study. Of the 402 assigned to receive the malaria vaccine, 32 developed clinical malaria vs 66 of 407 who received the rabies vaccine, a 53% reduction in risk (Bejon P et al. N Engl J Med. 2008;359[24]:2521-2532).

In the second study, 340 Tanzanian infants received the RTS, S/AS02D vaccine or the hepatitis B vaccine at 8, 12, and 16 weeks of age. All of the infants also received a vaccine against diphtheria, tetanus, pertussis, and Haemophilus influenzae B . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?